News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Epstein David M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| Epstein David M. (SEE REMARKS) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Sold 25,000 shares
@ $6.7, valued at
$167.5k
|
|
| 02/17/2022 |
4
| Epstein David M. (SEE REMARKS) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.79, valued at
$1.1M
|
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Epstein David M. (See Remarks) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Exercised 2,500 options to buy
@ $6.42, valued at
$16.1k
|
|
| 12/03/2020 |
4
| Epstein David M. (See Remarks) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Sold 10,923 shares
@ $32.6424, valued at
$356.6k
Sold 1,077 shares
@ $33.4455, valued at
$36k
Exercised 3,000 options to buy
@ $6.42, valued at
$19.3k
|
|
| 11/03/2020 |
4
| Epstein David M. (See Remarks) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Sold 11,917 shares
@ $31.1329, valued at
$371k
Sold 83 shares
@ $31.875, valued at
$2.6k
Exercised 3,000 options to buy
@ $6.42, valued at
$19.3k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Epstein David M. (See Remarks) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Converted 242,904 shares
@ $0
Converted 23,090 shares
@ $0
Converted 4,354 shares
@ $0
Converted 732,560 preferred shares
@ $0
Converted 69,636 preferred shares
@ $0
Converted 13,136 preferred shares
@ $0 |
|
| 01/31/2020 |
4
| Epstein David M. (See Remarks) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 278,532 options to buy
@ $19, valued at
$5.3M
|
|
| 10/16/2014 |
4
| Epstein David M. (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 104,935 shares
@ $0
Granted 188,182 shares
@ $1.1, valued at
$207k
Granted 39,091 shares
@ $1.1, valued at
$43k
Granted 103,500 options to buy
@ $1.5, valued at
$155.3k
Granted 21,500 options to buy
@ $1.5, valued at
$32.3k
|
|
| 07/24/2014 |
4
| Epstein David M. (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 06/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2010 |
4
| Epstein David M. (Sr. VP and CSO, Oncology) has filed a Form 4 on OSI PHARMACEUTICALS INC|
Txns:
| Disposed/sold 9,809 shares
@ $57.5, valued at
$564k
Unknown transaction of 3,531 shares
@ $57.5, valued at
$203k
Disposed/sold 7,084 options to buy
@ $26.21, valued at
$185.7k
Disposed/sold 4,000 options to buy
@ $37.74, valued at
$151k
Disposed/sold 17,500 options to buy
@ $47.29, valued at
$827.6k
Disposed/sold 11,250 options to buy
@ $35.4, valued at
$398.3k
Disposed/sold 22,500 options to buy
@ $33.62, valued at
$756.5k
|
|
| 05/04/2010 |
4
| Epstein David M. (Sr. VP and CSO, Oncology) has filed a Form 4 on OSI PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 906 shares
@ $58.67, valued at
$53.2k
|
|
|
|